Articles related to DIGITAL HEALTH

Philips Respironics has established a consent decree with US regulators to ensure the safety and compliance of their sleep and respiratory care devices, focusing on stringent remediation and continued patient support amidst ongoing sales restrictions.

Explore the potential of Rejoyn™, a digital therapeutic now cleared by the FDA, which has shown to significantly reduce depressive symptoms in adults as an adjunct to traditional outpatient care, without any reported adverse events.

In the realm of dermatology, AI and ML are not just futuristic concepts but practical tools enhancing diagnostic precision, patient care, and administrative efficiency. These technologies are reshaping how dermatologists interact with data, patients, and their own continuing education.

Join a confluence of experts at the Mayo Clinic Innovations in Gastroenterology and Hepatology 2024, where the latest advancements in AI, digital tools, and endoscopic technology promise to redefine patient care in gastroenterology and hepatology.

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.

In a significant stride toward personalized medicine, researchers have utilized AI to unveil two distinct evotypes of prostate cancer, heralding a new era in the disease’s diagnosis and management. This pivotal discovery opens doors to tailored treatment strategies, potentially mitigating the adverse effects of over-treatment in prostate cancer.